US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 19.060
  • -0.820-4.12%
Close Jun 18 16:00 ET
  • 19.330
  • +0.270+1.42%
Post 19:25 ET
1.62BMarket Cap-5882P/E (TTM)

Syndax Pharmaceuticals Key Stats

Syndax Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.85

-44.07%

Strong Buy

Jun 19, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.346M--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Feb 27, 20242023/Q40.000 / 0.000--
Nov 2, 20232023/Q30.000 / 0.000--
Aug 3, 20232023/Q20.000 / 0.000--
May 8, 20232023/Q10.000 / 500.000K--
Feb 28, 20232022/Q40.000 / 428.570K--
Nov 3, 20222022/Q30.000 / 600.000K--
Aug 8, 20222022/Q20.000 / 1.100M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.346M--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Feb 27, 20242023/Q40.000 / 0.000--
Nov 2, 20232023/Q30.000 / 0.000--
Aug 3, 20232023/Q20.000 / 0.000--
May 8, 20232023/Q10.000 / 500.000K--
Feb 28, 20232022/Q40.000 / 428.570K--
Nov 3, 20222022/Q30.000 / 600.000K--
Aug 8, 20222022/Q20.000 / 1.100M--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 19, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg